Journals / Güncel Retina Dergisi / 2021 / Cilt: 5 - Sayı: 2

Stargardt and Fundus Flavimaculatus; Pathophysiology, Clinical Findings, Imaging Characteristics and Diagnosis

Stargardt ve Fundus Flavimakulatus; Patofizyoloji, Klinik Bulgular, Görüntüleme Bulguları ve Tanı

Pages
185–189
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The typical sign of “choroidal silence” or dark choroid on fluorescein angiography (FA) is not present in all patients with STGD and is not specific to this condition.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Stargardt disease (STGD) is the most common form of recessively inherited macular dystrophy.
📊
Key Findings & Data:It is characterized by the presence of an atrophic macular lesion, which is surrounded by irregular, white-yellow, deep retinal lesions (flecks).
💡
Conclusion & Impact:The typical sign of “choroidal silence” or dark choroid on fluorescein angiography (FA) is not present in all patients with STGD and is not specific to this condition.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Stargardt disease (STGD) is the most common form of recessively inherited macular dystrophy. It is characterized by the presence of an atrophic macular lesion, which is surrounded by irregular, white-yellow, deep retinal lesions (flecks). There is wide variability in age at onset, visual acuity, fundus appearance, and severity of the disease. Fundus examination can be normal but visual acuity can be reduced early in the course of the disease. In these patients, pattern electroretinogram (PERG) and fundus autofluorescence (FAF) will be helped in establishing the diagnosis of STGD. The typical sign of “choroidal silence” or dark choroid on fluorescein angiography (FA) is not present in all patients with STGD and is not specific to this condition.

Özet

Stargardt hastalığı (STGD), resesif olarak geçiş gösteren maküla distrofileri içinde en sık görülen formdur. Atrofik bir maküla ile onu çevreleyen irregüler, sarı-beyaz renkli, derin retinal lezyonlar ile karekterizedir. Hastalar arasında başlangıç yaşı, görme keskinliği, fundus görünümü ve hastalık şiddeti açısından büyük değişkenlikler vardır. Hastalığın seyri esnasında erken dönemlerde fundus muayenesi normal olmasına karşın görme keskinliği azalmış olabilir. Bu tür hastalarda STGD tanısı koymada pattern elektroretinogram (PERG) ve fundus otofloresans (FOF) tanı koymada çok yardımcı yöntemlerdir. Fluoressein anjiografideki “koroidal sessizlik” ya da karanlık koroid görüntüsü STGD’li hastaların hepsinde görülmez ve sadece bu hastalığa özgün bir bulgu değildir.

🔖

Cite This Article

MENTEŞ, J., MENTEŞ, J. (2021). Stargardt and Fundus Flavimaculatus; Pathophysiology, Clinical Findings, Imaging Characteristics and Diagnosis. Güncel Retina Dergisi, Cilt: 5 - Sayı: 2, 185–189. https://ajindex.com/articles/224227

References (12)

  1. Lois N. New perspectives in Stargardt’s disease. In: Holtz FG, Spaide RF, eds. Essentials in Ophthalmology, Medical Retina. Berlin: Springer; 2007.p.165-181.
  2. Deutman AF. Macular Dystrophies, In: Ryan SJ, Ogden TE, Schachat PA, et al, eds. Retina. Vol2, 2nd ed. St Louis: Mosby; 1994.p.1186-1240.
  3. Donosa LA, Edwards AO, Frost A, Vrabec T, Stone EM, Hageman GS, et al. Autosomal dominant Stargardt-like macular dystrophy. Survey of Ophthalmology 2001;46(2):149-163.
  4. Armstrong JD, Meyer D, Xu S, Elfervig JL: Long-term follow-up of Stargardt’s disease and Fundus Flavimaculatus. Ophthalmology 1998;105(3):448-457.
  5. Kim LS, Fishman GA: Comparison of visual acuity loss in patients with different stages of Stargardt’s disease. Ophthalmology 2006;113(10):1748-1751.
  6. Sunnes JS, Steiner JN: Retinal function and loss of autofluorescence in Stargardt disease. Retina 2008;28(6):794-800.
  7. Şentürk F, Karaçorlu S, Özdemir H, Karaçorlu M. Stargardt hastalığındaki multifokal elektroretinografi değişiklikleri. Ret-Vit 2008;16(3):182-186.
  8. Shen LL, Sun M, Grossetta Nardini HK, Del Priore LV. Natural History of Autosomal Recessive Stargardt Disease in Untreated Eyes: A Systematic Review and Meta-analysis of Study- and Individual-Level Data. Ophthalmology 2019;126(9):1288-1296.
  9. Strauss RW, Muñoz B, Ho A, Jha A, Michaelides M, Cideciyan AV, et al. Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9). JAMA Ophthalmol. 2017;135(11):1232-1241.
  10. Strauss RW, Kong X, Ho A, Jha A, West S, Ip M, et al. Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 12-Month Period: ProgStar Report No. 11. JAMA Ophthalmol. 2019;137(10):1134-1145.
  11. Lois N, Halfyard AS, Bird AC, Holder GE, Fitzke FW. Fundus autofluorescence in Stargardt macular dystrophy-Fundus Flavimaculatus. Am J Ophthalmol 2004;138(1):55-62.
  12. Kong X, Ho A, Munoz B, West S, Strauss RW, Jha A, et al. Reproducibility of Measurements of Retinal Structural Parameters Using Optical Coherence Tomography in Stargardt Disease. Transl Vis Sci Technol. 2019;8(3):46.